130 related articles for article (PubMed ID: 1968353)
1. Evaluation of sulphasalazine in ankylosing spondylitis--an interventional study.
Fraser SM; Sturrock RD
Br J Rheumatol; 1990 Feb; 29(1):37-9. PubMed ID: 1968353
[TBL] [Abstract][Full Text] [Related]
2. Sulphasalazine in ankylosing spondylitis.
Feltelius N; Hällgren R
Ann Rheum Dis; 1986 May; 45(5):396-9. PubMed ID: 2872857
[TBL] [Abstract][Full Text] [Related]
3. [Sulfasalazine in the treatment of ankylosing spondylitis].
Krajnc I
Lijec Vjesn; 1990; 112(5-6):171-4. PubMed ID: 1978212
[TBL] [Abstract][Full Text] [Related]
4. Sulphasalazine and ankylosing spondylitis.
McConkey B
Br J Rheumatol; 1990 Feb; 29(1):2-3. PubMed ID: 1968352
[No Abstract] [Full Text] [Related]
5. Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.
Dougados M; Boumier P; Amor B
Br Med J (Clin Res Ed); 1986 Oct; 293(6552):911-4. PubMed ID: 2876744
[TBL] [Abstract][Full Text] [Related]
6. A controlled trial of sulphasalazine treatment of chronic ankylosing spondylitis: failure to demonstrate a clinical effect.
Corkill MM; Jobanputra P; Gibson T; Macfarlane DG
Br J Rheumatol; 1990 Feb; 29(1):41-5. PubMed ID: 1968354
[TBL] [Abstract][Full Text] [Related]
7. Sulphasalazine in ankylosing spondylitis. A radiological, clinical and laboratory assessment.
Taylor HG; Beswick EJ; Dawes PT
Clin Rheumatol; 1991 Mar; 10(1):43-8. PubMed ID: 1676621
[TBL] [Abstract][Full Text] [Related]
8. Sulfasalazine for ankylosing spondylitis.
Chen J; Liu C
Cochrane Database Syst Rev; 2005 Apr; (2):CD004800. PubMed ID: 15846731
[TBL] [Abstract][Full Text] [Related]
9. [Sulfasalazine therapy in spondylarthritis ankylopoietica].
Winkler V
Orv Hetil; 1989 Jan; 130(2):77-81. PubMed ID: 2563308
[TBL] [Abstract][Full Text] [Related]
10. Disease-modifying effect of etanercept versus sulphasalazine on spinal mobility in patients with ankylosing spondylitis.
Hendrix S; Koenig A; Li W; Singh A
J Int Med Res; 2013 Oct; 41(5):1606-11. PubMed ID: 23975857
[TBL] [Abstract][Full Text] [Related]
11. Conventional DMARD therapy (methotrexate-sulphasalazine) may decrease the requirement of biologics in routine practice of ankylosing spondylitis patients: a real-life experience.
Can M; Aydın SZ; Niğdelioğlu A; Atagündüz P; Direskeneli H
Int J Rheum Dis; 2012 Dec; 15(6):526-30. PubMed ID: 23253235
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of methotrexate in the treatment of ankylosing spondylitis: a three-year open study.
Biasi D; Carletto A; Caramaschi P; Pacor ML; Maleknia T; Bambara LM
Clin Rheumatol; 2000; 19(2):114-7. PubMed ID: 10791621
[TBL] [Abstract][Full Text] [Related]
13. Sulphasalazine therapy in ankylosing spondylitis: its effect on disease activity, immunoglobulin A and the complex immunoglobulin A-alpha-1-antitrypsin.
Davis MJ; Dawes PT; Beswick E; Lewin IV; Stanworth DR
Br J Rheumatol; 1989 Oct; 28(5):410-3. PubMed ID: 2571386
[TBL] [Abstract][Full Text] [Related]
14. Raised circulating levels of the eosinophil cationic protein in ankylosing spondylitis: relation with the inflammatory activity and the influence of sulphasalazine treatment.
Feltelius N; Hällgren R; Venge P
Ann Rheum Dis; 1987 May; 46(5):403-7. PubMed ID: 2884933
[TBL] [Abstract][Full Text] [Related]
15. Is sulfasalazine effective in ankylosing spondylitis? A systematic review of randomized controlled trials.
Chen J; Liu C
J Rheumatol; 2006 Apr; 33(4):722-31. PubMed ID: 16583475
[TBL] [Abstract][Full Text] [Related]
16. Sulphasalazine (Salazopyrin) in the treatment of enterogenic reactive synovitis and ankylosing spondylitis with peripheral arthritis.
Mielants H; Veys EM; Joos R
Clin Rheumatol; 1986 Jan; 5(1):80-3. PubMed ID: 2869851
[TBL] [Abstract][Full Text] [Related]
17. Sulphasalazine and ankylosing spondylitis: an open pilot study.
Coelho Andrade LE; Atra E; Bosi Ferraz M
Clin Exp Rheumatol; 1989; 7(6):661-2. PubMed ID: 2575477
[No Abstract] [Full Text] [Related]
18. The course of established ankylosing spondylitis and the effects of sulphasalazine over 3 years.
Kirwan J; Edwards A; Huitfeldt B; Thompson P; Currey H
Br J Rheumatol; 1993 Aug; 32(8):729-33. PubMed ID: 8102305
[TBL] [Abstract][Full Text] [Related]
19. Facial palsy and partial accommodative insufficiency associated with sulphasalazine treatment in a patient with ankylosing spondylitis.
Magnus JH; Elverland HH; Olsen EG; Husby G
Scand J Rheumatol; 1993; 22(4):199-201. PubMed ID: 8102809
[TBL] [Abstract][Full Text] [Related]
20. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.
Tsang HHL; Chung HY
J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
